Estradiol induces proliferation of keratinocytes via a receptor mediated mechanism

S Verdier-Sevrain1, M Yaar, J Cantatore

  • 1Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118-2394, USA.

Insights

Estradiol stimulates neonatal keratinocyte proliferation by binding to estrogen receptors (ER-alpha and ER-beta). This effect involves both genomic and non-genomic signaling pathways, highlighting estradiol

Area of Science:

  • Dermatology
  • Endocrinology
  • Cell Biology

Background:

  • Neonatal keratinocytes play a crucial role in skin development and barrier function.
  • Estrogen signaling is known to influence various cell types, but its specific role in neonatal keratinocytes requires further elucidation.

Purpose of the Study:

  • To investigate the effects of estradiol on neonatal keratinocyte proliferation.
  • To determine the expression of estrogen receptor (ER) isoforms in neonatal keratinocytes.
  • To elucidate the signaling mechanisms underlying estradiol-mediated keratinocyte growth.

Main Methods:

  • Binding assays to quantify estradiol interaction with keratinocytes.
  • Immunohistochemistry and Western blotting to detect ER-alpha and ER-beta expression.
  • Cell proliferation assays in the presence and absence of estradiol and anti-estrogens.
  • Analysis of intracellular signaling pathways, including extracellular signal-regulated kinases (ERK 1/2).

Main Results:

  • Estradiol binds to neonatal keratinocytes with high affinity, confirming specific estrogen binding sites.
  • Keratinocytes express both ER-alpha and ER-beta isoforms.
  • Estradiol up-regulates ER-alpha and induces keratinocyte proliferation, an effect dependent on functional estrogen receptors.
  • Estradiol-induced proliferation is mediated by both non-genomic (membrane-associated ERK 1/2 activation) and genomic (nuclear receptor activation) pathways.

Conclusions:

  • Estradiol significantly influences neonatal keratinocyte proliferation through specific estrogen receptor interactions.
  • Both genomic and non-genomic signaling pathways are involved in estradiol's proliferative effects on keratinocytes.
  • These findings suggest a role for estrogen in neonatal skin development and homeostasis.

Related Concept Videos

Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...